Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥2.71T2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥3.36T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥2.57T2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥37.2bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥37.5bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥50.2bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥65.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥49.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥53.7bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥56.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥28.3bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥29.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥36.7bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥37.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥1.87Tat 2023-12-31Cons.Assets
Total assets¥1.71Tat 2023-03-31Cons.Assets
Total assets¥1.81Tat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.16Tat 2023-12-31Cons.Liabilities
Total liabilities¥1.02Tat 2023-03-31Cons.Liabilities
Net assets / equity¥712.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥688.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥678.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥214.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥195.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥133.192023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.82023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.822022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥142.162022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.652022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥179.122022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥136.42022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio31.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥2.2bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥2.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥30m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥86.7bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥86.7bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2023-04-01 → 2023-12-31¥883.0bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2023-04-01 → 2023-12-31¥882.8bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥231m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2023-04-01 → 2023-12-31¥22.0bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.75T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.75T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥2.0bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥13.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥2.72T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥2.71T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥2.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥37.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥44m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2022-04-01 → 2022-12-31¥848.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2022-04-01 → 2022-12-31¥847.9bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥253m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.1bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.67T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.66T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥37.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 385
ItemContextValueUnit
Gain on step acquisitions eiCurrentYTDDuration1253000000JPY
Gain on sales of investment securities eiPrior1YTDDuration13044000000JPY
Gain on sales of investment securities eiCurrentYTDDuration451000000JPY
Compensation income eiPrior1YTDDuration-JPY
Compensation income eiCurrentYTDDuration1944000000JPY
Other eiPrior1YTDDuration10000000JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration13103000000JPY
Extraordinary incomeCurrentYTDDuration3653000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration161000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration22000000JPY
Impairment loss elPrior1YTDDuration106000000JPY
Impairment loss elCurrentYTDDuration67000000JPY
Loss on valuation of investment securities elPrior1YTDDuration5812000000JPY
Loss on valuation of investment securities elCurrentYTDDuration69000000JPY
Other elPrior1YTDDuration258000000JPY
Other elCurrentYTDDuration8000000JPY
Extraordinary lossPrior1YTDDuration6338000000JPY
Extraordinary lossCurrentYTDDuration168000000JPY
Income before income taxesPrior1YTDDuration56673000000JPY
Income before income taxesCurrentYTDDuration53725000000JPY
Income taxes currentPrior1YTDDuration22146000000JPY
Income taxes currentCurrentYTDDuration19238000000JPY
Income taxes deferredPrior1YTDDuration-2606000000JPY
Income taxes deferredCurrentYTDDuration-2249000000JPY
Income taxesPrior1YTDDuration19539000000JPY
Income taxesCurrentYTDDuration16988000000JPY
Profit lossPrior1YTDDuration37134000000JPY
Profit lossCurrentYTDDuration36736000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration7285000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration8450000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration29848000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration28286000000JPY
Profit lossPrior1YTDDuration37134000000JPY
Profit lossCurrentYTDDuration36736000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration3174000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration2845000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-34000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration20000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-374000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration177000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration1086000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration862000000JPY
Other comprehensive incomePrior1YTDDuration3852000000JPY
Other comprehensive incomeCurrentYTDDuration3906000000JPY
Comprehensive incomePrior1YTDDuration40986000000JPY
Comprehensive incomeCurrentYTDDuration40643000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration32866000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration32053000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration8120000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass